FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles

FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles

Submitted by admin on March 1, 2023 - 7:07pm
Source: 
Yahoo/Benzinga
News Tags: 
Regeneron
Sanofi
FDA
Kevzara
Sarilumab
polymyalgia rheumatica
Headline: 
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
snippet: 

The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Kevzara (sarilumab) for polymyalgia rheumatica (PMR), an inflammatory rheumatic disease,

Do Not Allow Advertisers to Use My Personal information